Molecular and Biological Aspects of AZT Resistant Viruses Derived from HIV-1 Infected Individuals

Arnold E. Jacobo-Molina A. Nanni R.G. Williams L. Lu X. Ding J. Clark D. Jr Zhang A. Ferris A.L. Clark P. Hizi A. , and Hughes H. (1992) Structure of HIV-1 reverse transcriptase/ DNA complex at 7 Å resolution showing active site locations. Nature 357: 85–89.

Biesert L. Zimmermann F. Schroder B. Matthes E. Suhartono H. Dietrich U. , and Rubsamen-Waigmann H. (1991) Biochemical and genetical analysis of AZT resistant HIV-mutants. Behring Institute Mitt 89: 74–80.

Blum M.R. Liao S.H.T. Good S.S. , and de Miranda P. (1988) Pharmacokinetics and bioavailability of zidovudine in humans. Am J Med 85: 189–194.

Boucher C.A.B. Tersmette M. Lange J.M.A. Kellam P. De Goede R.E.Y. Mulder J.W. Darby G. Goudsmit J. , and Larder B.A. (1990) Emergence of human immunodeficiency virus with reduced sensitivity to zidovudine in asymptomatic ‘high-risk’ individuals. Lancet i: 585–590.

Boucher C.A.B. O'Sullivan E. Mulder J. Chitra R. Kellam P. Darby G. Lange J.M.A. Goudsmit J. , and Larder B.A. (1992) Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects. J Infect Dis 165: 105–110.

Broadhurst K. Levantis P. Ball A. Gunkel N. Goh B. Forster G. Colvin B.T. Dourmashkin R. Jackson G.G. , and Oxford J.S. (1990) Characterisation of sensitive and resistant strains of HIV-1 to AZT in a cohort of patients at The London Hospital. Antiviral Res 15: 113.

Christophers J. , and Sutton R.N.P. (1987) Characterisation of acyclovir-resistant and sensitive clinical herpes simplex virus isolates from an immunocompromised patient. J Antimicrob Chemother 20: 389–398.

Coen D.M. , and Schaffer P.A. (1980) Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1. Proc Natl Acad Sci, USA 77: 2265–2269.

Coen D.M. Kosz-Vnechak M. Jacobson J.G. Lieb D.A. Bogard C.L. Schaffer P.A. Tyler K.L. , and Knipe D.A. (1989) Thymidine kinase negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc Natl Acad Sci, USA 86: 4736–4740.

Cohen K.A. Hopkins J. Ingraham R.H. Pargellis C. Wu J.C. Palladino D.E.H. Kinkade P. Warren T.C. Rogers S. Adams J. Farina P.R. , and Grob P.M. (1991) Characterization of the binding site for Nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase. J Biol Chem 266: 14670–14674.

Collins P. Larder B.A. Oliver N.M. Kemp S. Smith J.W. , and Darby G. (1989) Characterisations of DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir. J Gen Virol 70: 375–382.

Darby G. , and Larder B.A. (1992) The clinical significance of antiviral drug resistance. Res in Virol 143: 116–120.

Davies J.F. Hostomska Z. Hostomsky Z. Jordon S.R. , and Matthews D.A. (1991) Crystal structure of the ribonuclease domain of HIV-1 reverse transcriptase. Science 252: 88–95.

Drew W.L. Miner R.C. Bush D.F. (1991) Prevalence of resistance in patients receiving gancyclovir for serious cytomegalovirus infection. J Infect Dis 163: 716–719.

Field H.J. Darby G. , and Wiley P. (1980) Isolation and characterisation of acyclovir-resistant mutants of herpes simplex virus. J Gen Virol 49: 115–124.

Field H.J. , and Coen D.M. (1980) Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene. J Virol 60: 286–289.

Furfine E.S. , and Reardon J.E. (1991) Reverse transcriptase RNase H from the human immunodeficiency virus. Relationship of the DNA polymerase and RNA hydrolysis activities. J Biol Chem 266: 406–412.

Furman P.A. Fyfe J.A. St. Clair M.H. Weinhold K. Rideout J.E.L. Freeman G.A. Lehrman S.N. Bolognesi D.P. Broder S. Mitsuya H. , and Berry D.W. (1986) Phosphorylation of 3′-azidodeoxythmidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci, USA 83: 8333–8337.

Fyfe J.A. Keller P.M. Furman P.A. Miller R.L. , and Elion G.B. (1978) Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2)-hydroxyethoxymethyl) guanine. J Biol Chem 253: 8721–8727.

Gately A. Gander R.M. Johnson P.C. Kit S. Otsuke H. , and Kohl S. (1990) Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS. J Infect Dis 161: 711–715.

Gollapudi S. , and Gupta S. (1990) Human immunodeficiency virus 1 induced expression of P-glycoprotein. Biochem Biophys Res Commun 171: 1002–1007.

Goldman M.E. Nunberg J.H. O'Brien J.A. Quinter J.C. Schleif W.A. Freund K.F. Gaul S.L. Sauri W.S. Wai J.S. Hoffman J.M. Anderson P.S. Hupe D.J. Emini E.A. , and Stern A.M. (1991) Pyridinone derivatives: Specific human immunodeficiency virus type 1 reverse transriptase inhibitors with antiviral activity. Proc Natl Acad Sci, USA 88: 6863–6867.

Good S.S. Durack D.T. , and de Miranda P. (1986) Biotransformation in various species and in humans of 3′-azido-3′-deoxythymidine, a potential agent for the treatment of AIDS. Fed Proc 45: 444.

Good S.S. Koble C.S. Crouch R. Johnson R.L. Rideout J.L. , and Miranda P. (1990) Isolation and characterisation of an ether glycuronide of zidovudine, a major metabolite in monkeys and humans. Drug Metab Dispos 18: 321–326.

Good S.S. , and de Miranda P. (1992) Species differences in the metabolism of and disposition of antiviral nucleoside analogues: 2. Zidovudine. Antiviral Chem Chemoth 3: 65–77.

Gronowitz J.S. Lennerstrand J. Pettersson A. Neumuller M. Johansson M. , and Kallander C.F.R. (1992) Determination of IC₅₀ values and the mechanism of action of HIV RT inhibitors by the use of carrier bound template-primer, template, or primer, with ¹²⁵I-IUTP as substrate. Antiviral Chem Chemother 3: 203–213.

Johnson M.S. McClure M.A. Feng D.Y. Gray J. , and Doolittle R.F. (1986) Computer analysis of retroviral pol genes: assignment of enzyme functions to specific sequences and homologies with non-viral enzymes. Proc Natl Acad Sci, USA 83: 7648–7652.

Kohlstaedt L.A. Wang J. Friedman J.M. Rice P.A. , and Steitz T.A. (1992) Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256: 1783–1790.

Kellam P. Boucher C.A. , and Larder B.A. (1992) Fifth mutation in human immunodeficiency type 1 reverse transcriptase contributes to the development of high level resistance to zidovudine. Proc Natl Acad Sci, USA 89: 1934–1938.

Langtry H.D. , and Campoli-Richards M. (1989) Zidovudine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 37: 408–450.

Larder B.A. Purifoy D.J. Powell J. , and Darby G. (1987) Site specific mutagenesis of AIDS virus reverse transcrptase Nature 327: 716–717.

Larder B.A. , and Kemp S.D. (1989) Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 246: 1155–1158.

Larder B.A. Darby G. , and Richman D.D. (1989) HIV with reduced sensitivity to zidovudine isolated during prolonged therapy. Science 243: 1731–1734.

Larder B.A. Kellam P. , and Kemp S.D. (1991a) Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytes. AIDS 5: 137–144.

Larder B.A. Coates K.E. , and Kemp S.D. (1991b) Zidovudine-resistant human immunodeficiency virus selected by passage in cell culture. J Virol 65: 5232–5236.

Levantis P. , and Oxford J.S. (1992) Molecular aspects of AZT resistance in HIV-1. Res Virol 143: 136–142.

Lindborg B. (1992) The polymerase domains of human immunodeficiency virus type 1 reverse transcriptase and herpes simplex virus 1 DNA polymerase: their predicted three dimensional structures and some putative functions in comparison with E. coli DNA polymerase 1. A critical survey. Antiviral Chemo Chemoth 3: 223–241.

Lopez-Galindez C. Rojas J.M. Najera R. Richman D.D. , and Perucho M. (1991) Characterisation of genetic variation and 3′-azido-3′-deoxythymidine-resistance mutations of human immunodeficiency virus by the RNase A mismatch cleavage method. Proc Natl Acad Sci, USA 88: 4280–4284.

McLean A.R. Emery V.C. Webster A. , and Griffiths P.D. (1991) Population dynamics of HIV within an individual after treatment with zidovudine. AIDS 5: 485–489.

Martins L.V. Cheynier N. Asjö B. Meyerhans A. , and Wain-Hobson J. (1991) Independent fluctuation of human immunodeficiency virus type 1 rev and gp 41 quasi species in vivo. J Virol 65: 4502–4507.

de Miranda P. Burnette T.C. , and Good S.S. (1990) Tissue distribution and metabolic disposition of zidovudine in rats. Drug Metab Dispos 18: 315–320.

Mitsuya H. Weinhold K.J. Furman P.A. St. Clair M.H. Nusinoff-Lehrman S. Gallo R.C. Bolognesi D. Barry D.W. , and Broder S. (1985) 3′-azido-3′-deoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci, USA 82: 7096–7100.

Muckenthaier M. Gunkel N. Levantis P. Broadhurst K. Goh B. Colvin B. Forster G. Jackson G.G. , and Oxford J.S. (1992) Sequence analysis of an HIV-1 isolate which displays unusually high-level AZT resistance in vitro. J Med Virol 36: 79–83.

Myers G. Rabson A.B. Josephs S.F. Smith S.F. Berzofsky J.A. , and Wong-Staal F. (eds) (1989) Human retroviruses and AIDS: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos, NM: Theoretical Biology and Biophysics Group.

Nunberg J.H. Schlief W.A. Boots E.J. O'Brien J.H. Quntero J.C. Hoffman J.M. Emini E.A. , and Goldman M.E. (1991) Viral resistance to human immunodeficiency virus type 1.— specific pyridinone reverse transcriptase inhibitors. J Virol 65: 4887–4892.

Oxford J.S. , and Potter C.W. (1973) Amino adamantine resistance strains of influenza A2 virus. J Hygiene 72: 227–235.

Oxford J.S. Field H.J. , and Reeves D.S. (eds) (1986) Drug resistance in viruses, other microbes and eukaryotes. London: Academic Press, p. 232.

Pauwels R. Andries K. Desmyter J. Schols D. Kukula J.J. Breslin H.J. Raeymaeckers A. van Gelder J. Woestenborghs R. Heykanti J. Schellekens K. Janssen M.A.C. De Clercq E. , and Janssen P.A.J. (1990) Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature 343: 470–474.

Ratner L. Haseltine W. Patarca R. Livak K.J. Starcich B. Josephs S.F. Doran E.R. Rafalski J.A. Whitehorn E.A. Baumesiter K. Ivanhoff L. Petteway S.R. Jr Pearson M.L. Lautenberger J.A. Papas T.S. Ghrayeb J. Chang N.T. Gallo R.C. , and Wong-Stahl F. (1985) Complete nucleotide sequence of the AIDS virus, HTLV111. Nature 313: 277–284.

Remington K.M. Chesbro B. Wehrly K. Pedersen N.C. , and North T.W. (1991) Mutants of feline immunodeficiency virus resistant to 3′-azido-3′-deoxythymidine. J Virol 65: 308–312.

Richman D.D. Grimes J.M. , and Lagakos S.W. (1990) Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus. JAIDS 3: 743–746.

Richman D.D. Guatelli J.C. Grimes J. Tsiatis A. , and Gingeras T.R. (1991) Detection of mutations associated with zidovudine resistance in human immunodeficiency virus utilising the polymerase chain reaction. J Infect Dis 164: 1075–1081.

Richman D.D. (1992) The clinical significance of drug resistant mutants of human immunodeficiency virus. Res Virol 143: 130–131.

Richman D.D. Shik C.-K. Lowry I. Rose J. Prodanovich P. Goff S. , and Griffin J. (1991) Human immunodeficiency virus type 1 mutants resistant to non-nucleoside inhibitors of reverse transcriptase arise in tissue culture. Proc Natl Acad Sci, USA 85: 11241–11245.

Rooke, R., Tremblay, M., Sondyens, H., Destephano, L., Yao, X.-J., Fanning, M., Montaner, J.S.G., O'Shaughnessy, M.O., Gelmon, K., Tsoukas, C., Gill, J., Ruedy, J., Wainberg, M.A., and the Canadian Zidovudine Multi-Centre Study Group. (1989) Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy. AIDS 3: 411–415.

Rubsamen-Waigmann H. Schroder B. Biesert L. Bauermeister C.D. von-Briesan H. Suhartono H. Zimmermann F. Brede H.D. Regeniter A. Gerte S. (1991) Markers for HIV-disease progression in untreated patients and patients receiving AZT: evaluation of viral activity, AZT resistance serum cholesterol, beta 2 microglobulin, CD4+ cell counts and HIV antigen. Infection 19 Suppl. 2: 577–582.

St. Clair M.J. Richards C.A. Spector T. Weinhold K.J. Miller W.H. Langlois A.J. , and Furman P.A. (1987) 3′-azido-3′-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. Science 253: 1557–1559.

Schnipper L.E. , and Crumpacker C.S. (1980) Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci. Proc Natl Acad Sci, USA 77: 2270–2273.

Sibrach C.D. Gutman L.D. Wilffert C.M. McLaren C. St. Clair M.H. Keller P.M. , and Barry D.W. (1982) Pathogenicity of acyclovir herpes simplex type 1 from an immunodef icient child. J Infect Dis 146: 673–682.

Stein C. Levantis P. Lindborg B. Broadhurst K. Ball A. Jackson G.G. , and Oxford J.S. (1992) Drug resistant strains of HIV-1 show mutation at the active site of a reverse transcriptase model. Submitted.

Zhang I.Q. Simmonds P. Ludlam C.A. , and Leigh-Brown A.J. (1991) Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. AIDS 5: 675–681.